NRx Pharmaceuticals (NRXP) Metrics: History & Chart

NRx Pharmaceuticals, Inc.(NRXP)

Biotechnology · Wilmington, DE

$2.91+0.03 (+1.22%)

Delayed quote: Oct 6, 2026, 1:19 PM EDT

About NRx Pharmaceuticals, Inc.

NRx Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical firm focused on developing innovative therapies for disorders of the central nervous system and critical lung diseases. Its product portfolio features ZYESAMI, an experimental medication that has successfully completed Phase IIb/III clinical trials for treating respiratory failure associated with COVID-19. Additionally, the company is advancing NRX-100 and NRX-101, a pair of oral therapeutics designed to address bipolar depression, specifically in patients exhibiting acute or sub-acute suicidal thoughts and behaviors. Established in 2015, NRx Pharmaceuticals is headquartered in Wilmington, Delaware.

Wilmington, DE

29 employees

www.nrxpharma.com

Healthcare / Biotechnology

Sector: Healthcare
Industry: Biotechnology
CEO: Jonathan C. Javitt

View full financials

Third-Party DCF Estimate (FMP)	$0.68
Price Gap vs Third-Party Estimate	-76.18%

7D Total Return	0.00%
30D Total Return	-17.77%
YTD Total Return	+5.90%
1Y Total Return	-12.23%
3Y Total Return	+4.35%
5Y Total Return	-96.75%
10Y Total Return	N/A
15Y Total Return	N/A
20Y Total Return	N/A

2026	+5.90%
2025	+23.18%
2024	-52.17%
2023	-58.56%
2022	-76.78%
2021	-80.41%
2020

CAGR TTM	-12.18%
CAGR 3Y	+1.43%
CAGR 5Y	-49.61%
CAGR 10Y	N/A
CAGR 15Y	N/A
CAGR 20Y	N/A

PE Ratio	657.51
PE Ratio Avg TTM	814.59
PE Ratio Avg 3Y	814.59
Current VS TTM Avg	-19.28%
Current VS 3Y Avg	-19.28%
Current VS 5Y Avg	-19.28%

All Metrics

NRXP Valuation Metrics

NRXP Stock Price Metrics

NRXP Dividend Metrics

NRXP Growth Rate Metrics

NRXP Discounted Cash Flow Metrics

NRXP Returns By Period

NRXP Yearly Returns

NRXP Average Annual Returns By Period (CAGR)

NRXP Revenue Metrics

NRXP PE Ratio Metrics

NRXP PS Ratio Metrics

NRXP PB Ratio Metrics

NRXP Price to Free Cash Flow Ratio Metrics

NRXP Debt to Equity Ratio Metrics

NRXP PEG Ratio Metrics

NRXP FCF Yield

NRXP Earnings Yield

NRXP EBITDA Yield

NRXP OCF Yield

NRXP EV/EBIT Ratio Metrics

NRXP EV/EBITDA Ratio Metrics

NRXP EV/Assets Ratio Metrics

NRXP EV/Sales Ratio Metrics

NRXP Current Ratio Metrics

NRXP Quick Ratio Metrics

NRXP ROIC Metrics

NRXP Return on Assets Metrics

NRXP Return on Equity Metrics

NRXP Net Profit Margin Metrics

NRXP Gross Profit Margin Metrics

NRXP Tax Rate Metrics

PS Ratio	31.84
PS Ratio Avg TTM	108.18
PS Ratio Avg 3Y	108.18
Current VS TTM Avg	-70.57%
Current VS 3Y Avg	-70.57%
Current VS 5Y Avg	-70.57%

PB Ratio	62.51
PB Ratio Avg TTM	28.75
PB Ratio Avg 3Y	153.85
Current VS TTM Avg	+117.46%
Current VS 3Y Avg	-59.37%
Current VS 5Y Avg	-27.37%

PFCF Ratio	N/A
PFCF Ratio Avg TTM	N/A
PFCF Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Debt/Equity Ratio	(7.33)
Debt/Equity Ratio Avg TTM	(1.63)
Debt/Equity Ratio Avg 3Y	(0.35)
Current VS TTM Avg	-350.87%
Current VS 3Y Avg	-2013.55%
Current VS 5Y Avg	-3340.61%

PEG Ratio	N/A
PEG Ratio Avg TTM	N/A
PEG Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

FCF Yield	N/A
FCF Yield Avg TTM	N/A
FCF Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Earnings Yield	0.15%
Earnings Yield Avg TTM	0.12%
Earnings Yield Avg 3Y	0.11%
Current VS TTM Avg	+29.67%
Current VS 3Y Avg	+33.90%
Current VS 5Y Avg	+33.90%

EBITDA Yield	N/A
EBITDA Yield Avg TTM	N/A
EBITDA Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

OCF Yield	N/A
OCF Yield Avg TTM	N/A
OCF Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Ev/Ebit Ratio	N/A
Ev/Ebit Ratio Avg TTM	N/A
Ev/Ebit Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Ev/Ebitda Ratio	11369.81
Ev/Ebitda Ratio Avg TTM	523.18
Ev/Ebitda Ratio Avg 3Y	642.72
Current VS TTM Avg	+2073.20%
Current VS 3Y Avg	+1669.01%
Current VS 5Y Avg	+1669.01%

Ev/Assets Ratio	2.42
Ev/Assets Ratio Avg TTM	6.41
Ev/Assets Ratio Avg 3Y	6.01
Current VS TTM Avg	-62.25%
Current VS 3Y Avg	-59.73%
Current VS 5Y Avg	-66.71%

Ev/Sales Ratio	24.34
Ev/Sales Ratio Avg TTM	110.46
Ev/Sales Ratio Avg 3Y	110.46
Current VS TTM Avg	-77.96%
Current VS 3Y Avg	-77.96%
Current VS 5Y Avg	-77.96%

Current Ratio	0.86
Current Ratio Avg TTM	0.37
Current Ratio Avg 3Y	0.23
Current VS TTM Avg	+129.90%
Current VS 3Y Avg	+269.22%
Current VS 5Y Avg	+30.22%

Quick Ratio	0.86
Quick Ratio Avg TTM	0.37
Quick Ratio Avg 3Y	0.23
Current VS TTM Avg	+129.90%
Current VS 3Y Avg	+269.22%
Current VS 5Y Avg	+30.22%

ROIC	N/A
ROIC Avg 3Y	(413.61%)
ROIC Avg 5Y	(166.56%)
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A
Current VS 10Y Avg	N/A

ROA	(68.74%)
ROA Avg TTM	(92.05%)
ROA Avg 3Y	(77.19%)
Current VS TTM Avg	+25.33%
Current VS 3Y Avg	+10.95%
Current VS 5Y Avg	-43.66%

ROE	N/A
ROE Avg TTM	(390.03%)
ROE Avg 3Y	(230.45%)
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Net Profit Margin	(691.81%)
Net Profit Margin Avg TTM	(806.32%)
Net Profit Margin Avg 3Y	0.00%
Current VS TTM Avg	+14.20%
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Gross Profit Margin	58.78%
Gross Pft Margin Avg TTM	28.04%
Gross Pft Margin Avg 3Y	10.78%
Current VS TTM Avg	+109.63%
Current VS 3Y Avg	+445.04%
Current VS 5Y Avg	N/A

Tax Rate	0.00%
Tax Rate Avg 3Y	N/A
Tax Rate Avg 5Y	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A
Current VS 10Y Avg	-100.00%